Affinity Asset Advisors »

Ideaya Biosciences shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Ideaya Biosciences (IDYA) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Ideaya Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Ideaya Biosciences held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ideaya Biosciences by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $15M 400k 37.27

More positions owned by Affinity Asset Advisors

Roivant Sciences SHS (ROIV)
Apogee Therapeutics (APGE)
Spyre Therapeutics Com New (SYRE)
Xenon Pharmaceuticals (XENE)
Erasca (ERAS)
Alkermes SHS (ALKS)
Insmed Com Par $.01 (INSM)
Moderna Put Option (MRNA)
Praxis Precision Medicines I Com New (PRAX)
Oruka Therapeutics (ORKA)
Anaptysbio Inc Common (ANAB)
Avalo Therapeutics Com New (AVTX)
Cytokinetics Com New (CYTK)
Revolution Medicines (RVMD)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Affinity Asset Advisors

Top funds holding Ideaya Biosciences

FMR
BlackRock
Jupiter Topco
Henderson Group
Capital Research Global Investors
Baker Bros. Advisors
Vanguard Capital Management
State Street Corporation
Logos Global Management
Adage Capital Partners GP
Deerfield Management Company
Geode Capital Management
Morgan Stanley
Dimensional Fund Advisors
Alliancebernstein

View all funds holding Ideaya Biosciences